Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.
Journal of Clinical Investigation.
Times cited: 225
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors.
Times cited: 237